BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6141276)

  • 1. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists.
    DiTullio NW; Cieslinski L; Matthews WD; Storer B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):168-73. PubMed ID: 6141276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists.
    Angel I; Bidet S; Langer SZ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1098-103. PubMed ID: 2901484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of depression by clonidine of the pressor response to alpha 1-adrenoceptor agonists in pithed rats.
    Nomura S; Sunagane N; Uruno T; Kubota K
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):273-86. PubMed ID: 8829767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
    Angel I; Niddam R; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonic vocalization production of preweanling rats: effects of central and peripheral administration of alpha2-adrenoceptor agonists.
    Krall CM; Andicochea CT; McDougall SA
    Eur J Pharmacol; 2005 Jul; 517(3):200-7. PubMed ID: 15985263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
    Kawasaki H; Takasaki K
    J Pharmacol Exp Ther; 1986 Mar; 236(3):810-8. PubMed ID: 3005557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-dependent attenuation in alpha 2-adrenoreceptor-mediated nociception in experimental diabetes.
    Bitar MS; Pilcher CW
    Pharmacol Biochem Behav; 1997 Jan; 56(1):15-20. PubMed ID: 8981604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats.
    Yorimitsu M; Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Yokotani K
    Life Sci; 2008 Feb; 82(9-10):487-94. PubMed ID: 18201726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
    Hikasa Y; Ogasawara S; Takase K
    J Pharmacol Exp Ther; 1992 May; 261(2):746-54. PubMed ID: 1349647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of alpha-2 agonists and antagonists on gastric acid secretion.
    Bernardini C; Del Tacca M; Soldani G; Martinotti E
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):134-44. PubMed ID: 2875694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. St-93 hyperglycemia in Wistar rats.
    Thomas GP; Krishnamurthy A; Thapar GS; Varma RK
    Arch Int Pharmacodyn Ther; 1992; 315():79-86. PubMed ID: 1417366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and postsynaptic mechanisms in the clonidine- and oxymetazoline-induced inhibition of gastric motility in the rat.
    Zádori ZS; Shujaa N; Fülöp K; Dunkel P; Gyires K
    Neurochem Int; 2007 Oct; 51(5):297-305. PubMed ID: 17664022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-adrenoceptor agonists and antagonists on thyroid hormone secretion.
    Ahrén B
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):184-91. PubMed ID: 2857513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed.
    Pimentel AM; Costa CA; Carvalho LC; Brandão RM; Rangel BM; Tano T; Soares de Moura R; Resende AC
    Vascul Pharmacol; 2007 May; 46(5):353-9. PubMed ID: 17258511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clonidine on colonic motility in rats.
    Umezawa T; Guo S; Jiao Y; Hisamitsu T
    Auton Neurosci; 2003 Aug; 107(1):32-6. PubMed ID: 12927224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
    Hirohashi M; Tanaka M; Suzuki I; Akashi A
    Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of alpha-1 and alpha-2 adrenoceptors in peripheral imidazoline and adrenoceptor agonist-induced nociception.
    Dogrul A; Coskun I; Uzbay T
    Anesth Analg; 2006 Aug; 103(2):471-7, table of contents. PubMed ID: 16861437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
    Borhani AA; Houshmand G; Samini M; Namiranian K; Hajrasouliha AR; Tavakoli S; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2005 May; 514(2-3):183-9. PubMed ID: 15910805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits.
    Kim YI; Paik YH; Kang SS; Kim JH
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):66-76. PubMed ID: 6126161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.